Naquotinib mesylate

Catalog No. :
ACUEGI679
CAS No. :
1448237-05-5
Molecular Formula :
C31H46N8O6S
Molecular Weight :
658.83

IUPAC Name:(R)-5-((1-acryloylpyrrolidin-3-yl)oxy)-6-ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrazine-2-carboxamide methanesulfonate

Naquotinib mesylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$150.00Login to see priceInquiryInquiry
10mg98%$255.00Login to see priceInquiryInquiry
25mg98%$523.00Login to see priceInquiryInquiry
50mg98%$821.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameNaquotinib mesylate
IUPAC Name(R)-5-((1-acryloylpyrrolidin-3-yl)oxy)-6-ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrazine-2-carboxamide methanesulfonate
Molecular FormulaC31H46N8O6S
Molecular Weight658.83
SMILESO=C(C1=NC(CC)=C(O[C@H]2CN(C(C=C)=O)CC2)N=C1NC3=CC=C(N4CCC(N5CCN(C)CC5)CC4)C=C3)N.CS(=O)(O)=O
InChI KeyALDUQYYVQWGTMR-GJFSDDNBSA-N
SynonymNaquotinib (mesylate);Naquotinib mesylate (ASP8273 mesylate);ASP8273 (mesylate);EGFR,ASP8273,ErbB-1,ASP 8273,Inhibitor,Naquotinib mesylate,ASP-8273,HER1,Epidermal growth factor receptor,inhibit,Naquotinib;Naquotinib mesylate (ASP-8273)
CAS No.1448237-05-5

Synthetic Route by SureRoute

1. ACUEGI679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUEGI679 route product structure diagram
    ACUEGI6791448237-05-5
Inquiry

2. ACUEGI679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCYPD568 route compound structure diagram
    ACCYPD56853617-36-0
  4. Then
  5. ACUEGI679 route product structure diagram
    ACUEGI6791448237-05-5
Inquiry

Comments (0)